Milestone Scientific (NYSE:MLSS) Shares Down 4.1% – Time to Sell?

Shares of Milestone Scientific Inc. (NYSE:MLSS) traded down 4.1% on Thursday . The company traded as low as $0.90 and last traded at $0.92. 96,855 shares traded hands during trading, a decline of 44% from the average session volume of 172,570 shares. The stock had previously closed at $0.96.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Benchmark reaffirmed a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a report on Wednesday, November 20th. StockNews.com started coverage on Milestone Scientific in a research report on Saturday. They issued a “hold” rating on the stock.

Milestone Scientific Stock Performance

The firm has a market capitalization of $72.07 million, a P/E ratio of -13.22 and a beta of 1.41. The company has a 50-day moving average price of $1.13 and a 200-day moving average price of $0.96.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in MLSS. World Investment Advisors LLC bought a new position in shares of Milestone Scientific in the 3rd quarter worth $91,000. Renaissance Technologies LLC boosted its position in shares of Milestone Scientific by 72.8% in the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company’s stock worth $121,000 after purchasing an additional 53,198 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new position in shares of Milestone Scientific in the 3rd quarter worth $48,000. Geode Capital Management LLC boosted its position in shares of Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after purchasing an additional 31,572 shares during the last quarter. Finally, Carnegie Investment Counsel boosted its position in shares of Milestone Scientific by 18.9% in the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after purchasing an additional 27,412 shares during the last quarter. 5.79% of the stock is currently owned by institutional investors.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.